In accordance with previous studies30,31, the present results revealed that HIF-1α gene expression and protein level were significantly elevated in GC patient as compared to control group and were significantly associated with GC clinical stages (II, III, IV). The gene discussed is HIF1A; the disease is gastric cancer.